Summary

• Page properties (1 modified, 0 added, 0 removed)

Details

Page properties

Content

...	...	@@ -2,9 +2,9 @@
2	2	(((
3	3	(% class="container" %)
4	4	(((
5		-= //A new tridimensional diagnostic framework for neurodegenerative diseases// =
	5	+= //A new tridimensional diagnostic framework for CNS diseases// =
6	6
7		-This project is focused on developing a novel nosological and diagnostic framework for neurodegenerative diseases by using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies.
	7	+This project is focused on developing a novel nosological and diagnostic framework for CNS diseases by using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies.
8	8	We aim to create a structured, interpretable, and scalable diagnostic tool.
9	9	)))
10	10	)))
...	...	@@ -17,15 +17,16 @@
17	17
18	18	== **Overview** ==
19	19
20		-The //Tridimensional Diagnostic Framework// redefines how neurodegenerative diseases (NDD) are classified by focusing on:
	20	+The //Tridimensional Diagnostic Framework// redefines CNS diseases can be classified and diagnosed by focusing on:
21	21
22	22	* **Axis 1**: Etiology (genetic or other causes of diseases).
23	23	* **Axis 2**: Molecular Markers (biomarkers).
24	24	* **Axis 3**: Neuroanatomoclinical correlations (linking clinical symptoms to structural changes in the nervous system).
25	25
26		-[[Neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]]
27	27
	27	+[[For instance, neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]]
28	28
	29	+
29	29	This methodology enables:
30	30
31	31	* Greater precision in diagnosis.
...	...	@@ -32,14 +32,16 @@
32	32	* Integration of incomplete datasets using AI-driven probabilistic modeling.
33	33	* Stratification of patients for personalized treatment.
34	34
35		-== **Diagnostic Axes** ==
	36	+== **The case of neurodegenerative diseases** ==
36	36
	38	+There have been described these 3 diagnostic axes:
	39	+
37	37	* (((
38	38	**Axis 1: Etiology**
39	39
40	40	* //Description//: Focuses on genetic and sporadic causes, identifying risk factors and potential triggers.
41	41	* //Examples//: APOE ε4 as a genetic risk factor, or cardiovascular health affecting NDD progression.
42		-* //Tests//: Genetic testing, lifestyle and cardiovascular screening.
	45	+* //Tests//: Genetic testing, lifestyle, and cardiovascular screening.
43	43	)))
44	44	* (((
45	45	**Axis 2: Molecular Markers**
...	...	@@ -95,5 +95,6 @@
95	95	* `/outputs`: Generated models, visualizations, and reports.
96	96	* [[Methodology>>url:https://wiki.ebrains.eu/bin/view/Collabs/neurodiagnoses/Methodology/]]
97	97	* [[Results>>url:https://wiki.ebrains.eu/bin/view/Collabs/neurodiagnoses/Results/]]
	101	+* [[to-do-list>>to-do-list]]
98	98	)))
99	99	)))